Skip to content

Clinical trials

Adenocarcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Italy Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20082
20094
20104
20142
20151
20164
20173
20181
20191
20203
20214
20222
20234
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting10
Active, not recruiting5
Terminated4
Unknown status3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.3
European Institute of Oncology3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Novartis Pharmaceuticals3
AstraZeneca2
Eli Lilly and Company2
Hoffmann-La Roche2
Abbott1
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma45
Neoplasms15
Carcinoma12
Carcinoma, Non-Small-Cell Lung8
Digestive System Neoplasms8
Neoplasms by Site8
Neoplasms by Histologic Type7
Prostatic Neoplasms7
Digestive System Diseases6
Neoplasm Metastasis6

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.